Keyphrases
Bench to Bedside
100%
Precision Medicine
100%
Spherical nucleic Acids
100%
Oligonucleotides
36%
Immune Response
18%
Solid Tumors
18%
Small Interfering RNA (siRNA)
18%
Gene Regulatory Programs
18%
Toll-like
9%
Tumor
9%
Gene Expression
9%
Tumor Cells
9%
Cell Surface
9%
Nanoparticles
9%
Pattern Recognition Receptors
9%
Oncogene Expression
9%
Nuclease
9%
Immune Cells
9%
Cancer Therapeutics
9%
Agonistic
9%
Unmethylated CpG
9%
Early Phase Clinical Trials
9%
RNA-DNA
9%
First-in-human Clinical Trials
9%
RNA Oligonucleotide
9%
Nanotherapeutics
9%
DNA Oligonucleotides
9%
Immunostimulatory
9%
Antineoplastic Agents
9%
Transfection Reagent
9%
Freeform
9%
Immunostimulatory RNA
9%
3D Architecture
9%
Brain Penetrant
9%
Surface Pattern
9%
Immunostimulatory DNA
9%
Immunology and Microbiology
Immune Response
100%
Gene Expression
50%
Immunocompetent Cell
50%
Tumor Cell
50%
Genetic Transfection
50%
Cell Surface
50%
Antineoplastic Activity
50%
Pattern Recognition Receptor
50%
TLR9
50%
Nuclease
50%
Oncogene
50%
Biochemistry, Genetics and Molecular Biology
Nucleic Acid
100%
Oligonucleotide
45%
Clinical Trial
18%
Small Interfering RNA
18%
Immune Response
18%
Locus Control Region
18%
Gene Expression
9%
Antineoplastic Activity
9%
Transfection
9%
RNA
9%
Oncogene
9%
Pattern Recognition Receptor
9%
Immunocompetent Cell
9%
TLR9
9%
Nuclease
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nucleic Acid
100%
Oligonucleotide
45%
Neoplasm
18%
Clinical Trial
18%
Small Interfering RNA
18%
Solid Malignant Neoplasm
18%
Malignant Neoplasm
9%
Nanoparticle
9%
Nuclease
9%
Bioavailability
9%
Pattern Recognition Receptor
9%
Toll Like Receptor 9
9%
Neuroscience
Nucleic Acid
100%
Oligonucleotide
45%
Small Interfering RNA
18%
Gene Expression
9%
Oncogene
9%
Transfection
9%
TLR9
9%
Pattern Recognition Receptor
9%
Nuclease
9%